Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.